Low Expression LncRNA TUBA4B is a Poor Predictor of Prognosis and Regulates Cell Proliferation in Non-Small Cell Lung Cancer

被引:35
|
作者
Chen, Jian [1 ]
Hu, Lijuan [1 ]
Wang, Junjun [1 ]
Zhang, Fan [1 ]
Chen, Jie [2 ]
Xu, Gang [1 ]
Wang, Yumin [1 ]
Pan, Qinshi [1 ]
机构
[1] Wenzhou Med Univ, Dept Lab Med, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Dept Intens Care Unit, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Non-small cell lung cancer; lncRNAs; TUBA4B; Prognosis; LONG NONCODING RNA; PROSTATE-CANCER; GENE; METASTASIS; SURVIVAL; NSCLC; STATE;
D O I
10.1007/s12253-016-0089-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We aimed to unveil the clinical roles and biological function of lncRNA TUBA4B in on-small cell lung cancer (NSCLC). The relative expression level of TUBA4B was estimated by qPCR in 114 pairs of NSCLC and NT samples and the relation of TUBA4B to clinical data of NSCLC patients was analyzed. We found TUBA4B was lower expressed in NSCLC and five cell lines. The lower expression of TUBA4B was remarkably correlated with advanced TNM stage and lymph node metastasis and served as a predictor for overall survival of NSCLC. After overexpression of TUBA4B, cell proliferation ability of A549 and NCI-H1299 remarkably decreased. Our study ascertained low expression TUBA4B in NSCLC tissue, cell lines and is a poor predictor for prognosis and can regulate cell proliferation in NSCLC.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 50 条
  • [1] Downregulation of lncRNA TUBA4B is Associated with Poor Prognosis for Epithelial Ovarian Cancer
    Zhu, Fang-Fang
    Zheng, Fei-Yun
    Wang, Hai-Ou
    Zheng, Jing-Jie
    Zhang, Qian
    PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (02) : 419 - 425
  • [2] Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer
    He, Xuezhi
    Liu, Zhili
    Su, Jun
    Yang, Jinsong
    Yin, Dandan
    Han, Liang
    De, Wei
    Guo, Renhua
    TUMOR BIOLOGY, 2016, 37 (07) : 9503 - 9510
  • [3] AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer
    Al-Khafaji, Ahmed S. K.
    Marcus, Michael W.
    Davies, Michael P. A.
    Risk, Janet M.
    Shaw, Richard J.
    Field, John K.
    Liloglou, Triantafillos
    ONCOLOGY LETTERS, 2017, 13 (06) : 4463 - 4468
  • [4] Overexpression of CRKL Correlates With Poor Prognosis and Cell Proliferation in Non-Small Cell Lung Cancer
    Wang, Yan
    Dong, Qian-ze
    Fu, Ling
    Stoecker, Maggie
    Wang, Endi
    Wang, En-Hua
    MOLECULAR CARCINOGENESIS, 2013, 52 (11) : 890 - 899
  • [5] Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer
    Su, Wenmei
    Luo, Liang
    Wu, Fenping
    Lai, Zhennan
    Li, Xiaofang
    Xie, Zhong
    Tang, Zhi
    Yang, Zhixiong
    Hang, Rong
    HUMAN PATHOLOGY, 2015, 46 (05) : 732 - 738
  • [6] Association of low RKIP expression with poor prognosis in non-small cell lung cancer.
    Meng, Lingbin
    Ji, Rui
    Laber, Damian A.
    Yan, Xuebo
    Xu, Xiaochun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis
    He, Chaowen
    Huang, Dongxuan
    Yang, Fan
    Huang, Dongsheng
    Cao, Yahui
    Peng, Jianfeng
    Luo, Xiaohua
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 503 - 514
  • [8] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    X. Zhang
    Z. Wang
    Y. Kang
    X. Li
    X. Ma
    L. Ma
    Clinical and Translational Oncology, 2014, 16 : 178 - 183
  • [9] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    Zhang, X.
    Wang, Z.
    Kang, Y.
    Li, X.
    Ma, X.
    Ma, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (02): : 178 - 183
  • [10] High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer
    L. Ke
    S.-B. Xu
    J. Wang
    X.-L. Jiang
    M.-Q. Xu
    Clinical and Translational Oncology, 2017, 19 : 599 - 605